Injectable MPL allergy vaccine (Allergy Therapeutics)

注射用MPL过敏疫苗（Allergy Therapeutics）

Report date: 2025/03/21 10:47:00

Base Information

Drug NameInjectable MPL allergy vaccine (Allergy Therapeutics)
Drug Alias NameGrass MATA MPLGrass pollen modified allergen tyrosineadsorbedBirch pollen allergen extractRagweed MATA MPLBirch pollen modified allergen tyrosine-absorbed +[14] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHypersensitivity, ImmediateHypersensitivityConjunctivitis, Allergic +[6] 
Global Approved IndicationsHypersensitivityConjunctivitis, AllergicRhinitis, Allergic, Seasonal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2016/04/01
Country/TerritoryCzechiaCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAllergy Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAllergy Therapeutics
Inactive CompaniesN/A
Active IndicationsHypersensitivityConjunctivitis, AllergicRhinitis, Allergic, Seasonal +[4] 
Inactive IndicationsHypersensitivity, ImmediateRhinitis, Allergic

Other Information

ATC CodeV01AA02
Related LinksN/A